Clinical Assessment & Treatment Guidelines

Patient Summary

MODERN EVIDENCE-BASED TREATMENT

1. Immediate / Acute Phase

• Do NOT reduce BP abruptly. In an 83-year-old with longstanding hypertension, the cerebral autoregulation curve is shifted rightward. A rapid drop risks cerebral hypoperfusion, falls, and acute kidney injury.
• Target a 10-15% reduction in BP over 24-48 hours, then gradual titration over weeks.
• Oral agents are preferred over IV in urgency (no acute end-organ failure).
• Options for acute oral control: oral amlodipine (2.5-5 mg) or oral captopril (6.25-12.5 mg) - safe, titratable.

2. BP Target for Elderly Patients (>80 years)

• HYVET trial (patients >80 years): SBP target <150 mmHg for octogenarians - this was the first RCT to demonstrate benefit in this age group. Thiazide-like diuretic (indapamide) ± perindopril reduced stroke by 30% and CV death by 23%.
• SPRINT trial (≥75 years subgroup): Targeting SBP <120 mmHg reduced CV events and mortality by ~33-34% vs. <140 mmHg target. However, this came with more AKI events and electrolyte disturbances; patients require closer monitoring. - National Kidney Foundation Primer on Kidney Diseases
• ACC/AHA 2017 guideline: Goal BP <130/80 mmHg (this applies broadly including elderly, but must be individualized - goals need to be adjusted for frailty, fall risk, and AKI susceptibility).
• 2024 ESH guideline: Recognizes ACR 30-300 mg/g (A2) as HMOD - this patient's ACR of 65 mg/g confirms CKD-stage hypertensive kidney disease.
• A 2024 Cochrane review (PMID 39688187) on higher BP targets in older adults supports individualization.

3. Drug Selection - First-Line Choices

A. RAS Inhibitor (Top Priority)

"An ACEi or an ARB, titrated to the maximum tolerated doses, is recommended for patients with CKD and moderate (UACR 30-300 mg/g) albuminuria" (Class I, Level A evidence)

• ACE Inhibitor (e.g., Ramipril 2.5-5 mg/day, Perindopril 4-8 mg/day) OR
• ARB (e.g., Losartan 25-50 mg/day, Telmisartan 40-80 mg/day) - preferred if ACE-I cough develops
• RAS blockade is both antihypertensive AND renoprotective (reduces albuminuria, slows CKD progression)
• Do NOT combine ACE-I + ARB - dual RAS blockade increases adverse events (ONTARGET trial)
• Start low in elderly; monitor potassium and creatinine at 1-2 weeks (expect a small acceptable rise in creatinine ≤30%)

B. Add-on: Calcium Channel Blocker (CCB)

• Amlodipine 2.5-5 mg/day - excellent in elderly isolated systolic hypertension (arterial stiffness)
• Synergizes with ACE-I/ARB: CCB reduces peripheral resistance, RAS blocker protects kidneys
• Reduces risk of ankle edema when combined with RAS blockers vs. CCB alone
• Comprehensive Clinical Nephrology, 7th Ed.: Step 1 combination = ACEi/ARB + CCB (if eGFR ≥30)

C. Thiazide-like Diuretic (if needed as 3rd agent)

• Indapamide SR 1.5 mg/day (preferred over HCTZ in elderly - less metabolic disruption, used in HYVET)
• Caution: thiazides can worsen hyponatremia in elderly (impaired water dilution in aging kidneys)
• Use loop diuretic (furosemide) instead if eGFR <30 mL/min

D. Drugs to Avoid/Use Caution in this Patient

4. Monitoring Protocol

• BP at each visit; ABPM or home BP monitoring (office BP can be artificially elevated in elderly)
• Check ACR and creatinine/eGFR every 3-6 months
• Electrolytes (K+, Na+) within 2 weeks of starting/up-titrating RAS blockers or diuretics
• Postural BP measurements to screen for orthostatic hypotension
• Assess for falls risk, cognitive status, frailty

5. Non-Pharmacological (Lifestyle) - Modern

• Sodium restriction: <2g Na/day (2g Na = 5g salt) - especially effective: salt sensitivity >85% in elderly per Comprehensive Clinical Nephrology
• DASH diet: rich in potassium, calcium, magnesium - lowers BP 8-14 mmHg
• Potassium supplementation via diet (fruits, vegetables) - recommended by 2024 CKD-HTN guidelines (except in advanced CKD)
• Weight management, moderate aerobic activity (as tolerated by elderly patient)
• Avoid alcohol, smoking

AYURVEDIC TREATMENT APPROACH

Conceptual Framework

• Dosha imbalance: Predominantly Pitta-Vata type
  • Pitta: throbbing headache, heat, irritability, increased BP during exertion/emotion
  • Vata: aging-related, vascular stiffness (Rukshata), irregular lifestyle
• Srotorodha: Obstruction in Rasavaha and Raktavaha Srotas (blood channels)
• Dhatudushti: Specifically Rakta dhatu (blood/vascular tissue) and Mamsa/Meda dhatu disturbance
• Albuminuria corresponds to Shukra/Ojas dhatu kshaya + Vrikka (kidney) damage - called Vrikkaroga

Key Ayurvedic Herbs & Formulations

Classical Formulations for BP + Albuminuria

• Gokshuradi Guggulu - top choice when albuminuria is present
• Punarnavadi Kashaya (decoction) - renal-specific, reduces proteinuria
• Sarpagandha Ghana Vati - specific antihypertensive
• Brahmi Ghrita - for headache with BP (Pitta-Vata)
• Chandanasava / Usheerasava - cooling, Pitta shamak for throbbing headache

Panchakarma Therapies (for stable patients)

• Shirodhara (continuous oil stream on forehead) - reduces Pitta, calms CNS, excellent for chronic hypertensive headaches
• Takradhara (buttermilk stream) - effective in Pitta-predominant hypertension
• Basti (medicated enema with Vata-pacifying oils/decoctions) - targets Vata component of vascular stiffness
• Virechana (purgation) - for Pitta-Rakta purification; must be done cautiously in elderly

Ayurvedic Dietary Guidelines (Pathya)

• Avoid: Salt (Lavana), sour foods (Amla rasa), pungent spices, alcohol, tobacco, red meat, fermented foods, processed/canned foods
• Encourage: Pomegranate (Dadima), amla/gooseberry (Amalaki), garlic (Lasuna) in moderation, barley (Yava), green gram (Mudga), gourds, coconut water, banana
• Herbs in food: Turmeric (curcumin - anti-inflammatory, may reduce albuminuria), cumin, coriander, fennel
• Avoid excess Kapha-promoting foods: Curd at night, incompatible food combinations

Yoga & Pranayama

• Anulom-Vilom (Nadi Shodhana): Balances Vata-Pitta, lowers sympathetic tone
• Bhramari Pranayama: Reduces headache, calms nervous system
• Shavasana: Daily 15-20 minutes - proven to reduce cortisol and BP
• Avoid: Vigorous Kapalabhati or inverted postures (Shirsasana) with BP 190/80 - contraindicated until BP controlled

INTEGRATED TREATMENT SUMMARY

IMMEDIATE:
- Oral Amlodipine 5mg + Ramipril 2.5mg
- Reassess BP in 24-48 hrs; titrate gradually
- Monitor renal function + electrolytes in 2 weeks

SHORT-TERM (1-3 months):
- Target BP: 130-140 mmHg systolic
- Add Indapamide SR 1.5mg if needed
- Repeat ACR and eGFR at 3 months
- Start Sarpagandha Vati + Gokshuradi Guggulu + Punarnava (Ayurveda adjunct)
- Shirodhara 7-14 sessions for headache relief

LIFESTYLE:
- DASH diet + strict salt restriction (<2g Na/day)
- Anulom-Vilom + Bhramari + Shavasana daily
- Avoid NSAIDs, caffeine, excess salt

MONITORING:
- BP (postural check each visit for orthostasis)
- ACR, creatinine, K+, Na+ at 1-3 month intervals
- Fall risk assessment each visit

1. Sarpagandha contains reserpine - it can cause depression, nasal congestion, and GI upset. Avoid in patients with depression. It also interacts with antihypertensive drugs, potentially causing additive hypotension - use only under Ayurvedic physician supervision.
2. In this 83-year-old, falls prevention is as important as BP control - aggressive lowering risks orthostatic hypotension and fractures.
3. The ACR of 65 mg/g meets criteria for CKD-A2 category even if eGFR is preserved - get eGFR checked if not already done.
4. A 2025 Lancet systematic review (PMID 40902616) on intensive vs. standard BP control confirms cardiovascular benefit but highlights renal risks - reinforcing the need for individualized targets in elderly patients like this one.
5. Ayurvedic treatment should complement, not replace, modern antihypertensives in this high-risk patient.